AMSBIO's PluriPCR Kit is designed to be a quantitative, easy-to-use, and reliable assay of five genes strongly specific to pluripotency.
These genes: Oct-3/4, Nanog, DNMT3b, Dppa4, and Rex1
are expressed by human embryonic stem cells (hESC) and induced
pluripotent stem cells (iPSC); all are sharply down-regulated during
differentiation.
The kit will allow stem cell scientists to accurately and unambiguously define
the pluripotency of a cell line using existing real-time quantitative PCR
equipment. PluriPCR uses five key genes, in combination with a unique
normalization method, which gives a reliable and quantitative readout for
the pluripotency of a cell line. The kit is suited for all aspects of
pluripotent stem cell research: measure if culture conditions are resulting
in the loss of pluripotency, to assess successful nuclear reprogramming of
iPS cells, and even as a release assay in the manufacture and clinical
development of pluripotent stem cells.
The PluriPCR kit is optimized for routine quality control using either
two-step or one-step real-time quantitative PCR methods. The assay kit
combines multiple pluripotency and housekeeping markers and an analysis tool
to assess the pluripotency of your cell line. The resultant PluriPCR Index
is a simple method to understand if your pluripotent stem cells are
differentiating.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognised as a leading
international provider of unique & innovative products & custom
services for life sciences research. The AMSBIO range includes over 23,000
polyclonal & monoclonal antibodies, peptides, recombinant proteins,
extracellular matrix, molecular detection reagents, & tissue DNA, RNA,
protein & microarray products. Key research areas include: apoptosis,
cell invasion & migration, cell signaling, DNA damage, electrophoresis,
glycobiology, posttranslational modification & stem cell biology.